Safety and Efficacy of Long-Acting Liposomal Bupivacaine Plus Bupivacaine Hydrochloride for Dorsal Penile Block During Ambulatory Pediatric Urologic Surgery

Andrew T. Gabrielson*, Logan Galansky, Tamir Sholklapper, Isabella Florissi, Chad Crigger, Kelly Harris, Nora Haney, Hiten D. Patel, Ming Hsien Wang, Charlotte Wu, John P. Gearhart, Heather N. Di Carlo

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

This study evaluates the tolerability and efficacy of preoperative dorsal penile nerve block with Exparel plus bupivacaine hydrochloride in children>6 years old undergoing ambulatory urologic surgery. We demonstrate that the drug combination is well-tolerated, with appropriate analgesic efficacy in the recovery room as well as at 48-hour and 10-14 day follow-up periods. These preliminary data justify the need to perform a prospective, randomized trial comparing Exparel plus bupivacaine hydrochloride to other common local anesthetic regimens used in pediatric urologic surgery.

Original languageEnglish (US)
Pages (from-to)190-193
Number of pages4
JournalUrology
Volume176
DOIs
StatePublished - Jun 2023

Funding

Financial Disclosure : The authors have no conflicts of interest to disclose. This study was internally funded by the Robert Jeffs, MD Department of Pediatric Urology at Johns Hopkins Hospital.

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Safety and Efficacy of Long-Acting Liposomal Bupivacaine Plus Bupivacaine Hydrochloride for Dorsal Penile Block During Ambulatory Pediatric Urologic Surgery'. Together they form a unique fingerprint.

Cite this